Transient Metabolite Detection for Single-Cell Metabolomics and Diagnostics
Transient Metabolite Detection for Single-Cell Metabolomics and Diagnostics
批准号:
8358296
负责人:
Daniel Alan Heller
金额:
$274.35万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-30 至 2017-06-30
关键词:
BenchmarkingBindingCancer BiologyCellsClinical EngineeringDataDetectionDevelopmentDiagnosticEventFingerprintFluorescenceFutureGenomicsLifeLigandsMalignant NeoplasmsMeasurementMeasuresMetabolicMetabolismNanotubesNeoplasm MetastasisPharmaceutical PreparationsResearch PersonnelStagingTechniquesTimeToxicologyWorkabstractingcancer cellcancer diagnosisclinically relevantfunctional genomicshuman tissueimprovedmetabolomicsnanomaterialspublic health relevancesensorsingle walled carbon nanotubesmall molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Provided by the applicant)
Abstract: This work will develop the capability to spatially detect a wide range of metabolites quantitatively and in real- time within a single cell. Few techniques are available to measure metabolite concentrations, although they are a key indicator of a cell's genomic expression, and the capability of metabolite flux measurements, resolved spatially and transiently, is heretofore unrealized. This project will provide these abilities to benefit several fields, including metabolomics, functional genomics, toxicology, cancer biology, metabolic engineering, and clinical diagnostics. The sensors will consist of single-walled carbon nanotubes which emit photostable near-infrared fluorescence which is highly environmentally sensitive. The nanotubes will be functionalized with ligands which bind to important metabolites and the binding event will be transduced by spectral shifts in the nanotube's emission. The investigator's group will introduce these nanotube sensors into live cells in order to answer important questions relevant to cancer biology and cell metabolism. Concomitantly, the team will work towards the rapid and real-time detection of clinically-relevant metabolites for early cancer diagnosis and the benchmarking of metastasis. We will also re-construct multiplexed metabolite data in order to conduct single- cell metabolomic fingerprinting.
Public Health Relevance: Metabolites are small molecules produced in the body which may be used in the future to detect cancer at earlier stages, better understand the biology of cancer, and improve the development of important drugs. This project develops sensors using nanomaterials to detect many classes of metabolites within single cells and in human tissues.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.kint.2016.03.041
发表时间:
2016-10
期刊:
KIDNEY INTERNATIONAL
影响因子:
19.6
作者:
[Williams, Ryan M., Jaimes, Edgar A., Heller, Daniel A.]
通讯作者:
Heller, Daniel A.
DOI:
10.1021/acs.nanolett.9b00956
发表时间:
2019-07-01
期刊:
NANO LETTERS
影响因子:
10.8
作者:
[Harvey, Jackson D., Williams, Ryan M., Heller, Daniel A.]
通讯作者:
Heller, Daniel A.
Hyperspectral Microscopy of Near-Infrared Fluorescence Enables 17-Chirality Carbon Nanotube Imaging.
DOI:
10.1038/srep14167
发表时间:
2015-09-21
期刊:
Scientific reports
影响因子:
4.6
作者:
[Roxbury D, Jena PV, Williams RM, Enyedi B, Niethammer P, Marcet S, Verhaegen M, Blais-Ouellette S, Heller DA]
通讯作者:
Heller DA
Control of Carbon Nanotube Solvatochromic Response to Chemotherapeutic Agents.
碳纳米管溶剂化变色反应对化疗药物的控制。
DOI:
10.1021/acsami.7b12015
发表时间:
2017
期刊:
ACS applied materials & interfaces
影响因子:
9.5
作者:
[Harvey,JacksonD, Baker,HananA, Mercer,Elizabeth, Budhathoki-Uprety,Januka, Heller,DanielA]
通讯作者:
Heller,DanielA
DOI:
10.1021/ja505529n
发表时间:
2014-11-05
期刊:
Journal of the American Chemical Society
影响因子:
15
作者:
[Budhathoki-Uprety J, Jena PV, Roxbury D, Heller DA]
通讯作者:
Heller DA
共 9 条
Nanosensor Array Platform to Capture Whole Disease Fingerprints
-
批准号:10660707
-
项目类别:
-
资助金额:$69.66万
-
财政年份:2023
-
负责人:Daniel Alan Heller
-
依托单位:
Efficacy and pharmacokinetic assessment of renal-targeted therapy in a pig model of cisplatin induced acute kidney injury.
-
批准号:10384209
-
项目类别:
-
资助金额:$30.58万
-
财政年份:2021
-
负责人:Daniel Alan Heller
-
依托单位:
Tumor-Selective Delivery Approaches for Medulloblastoma
-
批准号:10320961
-
项目类别:
-
资助金额:$60.9万
-
财政年份:2020
-
负责人:Daniel Alan Heller
-
依托单位:
Tumor-Selective Delivery Approaches for Medulloblastoma
-
批准号:10543087
-
项目类别:
-
资助金额:$60.3万
-
财政年份:2020
-
负责人:Daniel Alan Heller
-
依托单位:
Renal tubule-specific nanotherapeutics for acute kidney injury
-
批准号:9982323
-
项目类别:
-
资助金额:$26.94万
-
财政年份:2018
-
负责人:Daniel Alan Heller
-
依托单位:
P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor Microenvironment
-
批准号:10310486
-
项目类别:
-
资助金额:$62.65万
-
财政年份:2017
-
负责人:Daniel Alan Heller
-
依托单位:
P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor Microenvironment
-
批准号:10061563
-
项目类别:
-
资助金额:$63.93万
-
财政年份:2017
-
负责人:Daniel Alan Heller
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: